If Bioton are successful in T/O they will still only have 48% of SIE shares as I read. Anyone know what that could mean for the value of remaining shares (for those who hold on)?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%